Carvacrol ameliorates cyclophosphamide-induced rat premature ovarian failure and uterine fibrosis via regulating PI3K/AKT/FOXO3a signaling pathway

Zeinab A El-Gendy, Seham Samir Soliman, Mohamed S Aly, Sara M Baraka · 2025

Read Carvacrol ameliorates cyclophosphamide-induced rat premature ovarian failure and uterine fibrosis via regulating PI3K/AKT/FOXO3a signaling pathway by Zeinab A El-Gendy, Seham Samir Soliman, Mohamed S Aly, Sara M Baraka (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12687504.txt.

Description

Zeinab El-Gendy and co-authors tested whether carvacrol, a plant compound, can shield rat ovaries from a chemotherapy drug that causes early ovarian failure, in a 2025 study. Such failure and loss of egg reserve are common costs of cancer care. Carvacrol had eased other drug side effects in past work, which made it a natural candidate here.

Twenty-four female rats were split into four groups: normal, carvacrol alone, the drug alone, and both together. The drug ran weekly for three weeks, and carvacrol was given daily by mouth. The compound steadied the rats' cycles, body weight, and hormone levels that the drug had upset. Tissue checks on ovary and womb backed the gains.

Catalog record

CREATORZeinab A El-Gendy, Seham Samir Soliman, Mohamed S Aly, Sara M Baraka
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE62 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12687504

Browse the full library · About the Tower of Babel